Biomedical Investment Fund
R&D Tax Incentive
R&D Tax incentive: How Australia is making clinical trials cost competitive:
The R&D Tax Incentive is the Australian Government’s principal measure to encourage industry investment in research and development. It is a broad-based, market driven program that aims to boost company competitiveness, improve productivity and deliver economy-wide benefits to Australia.
The R&D Tax Incentive replaces the R&D Tax Concession from 1 July 2011 and is jointly administered by AusIndustry (on behalf of Innovation Australia) and the Australian Taxation Office (ATO).
Planning to run a clinical trial in Australia?
43.5% “cash back” benefit now available for eligible foreign companies undertaking R&D in Australia.
To learn more about why you are entering the international market from Australia, please schedule an appointment with us.
因應智慧城市趨勢發展, 全球關注的淨零減碳工作刻不容緩, 互聯網將科技緊緊聯繫著我們, 跨洋過海, 即將到來的2023台北高雄「智慧城市展」吸引國際智慧城市前來參訪, 台灣是科技島, 世界正在看台灣。我們特別邀請澳洲昆士蘭商務局Trade & Investment Queensland, 於2023年3月27日, 參與【昆士蘭之夜】與台灣能源、關鍵材料及農業科技GTI們一同切磋及用餐, 引領盼望, 交流連結! 此次昆士蘭之夜我們很榮幸邀請到Bundaberg市長 John Dempsey, Scenic Rim市長 Gregory Christensen, Gladstone市長 Matt Burnett, 及Redlands副市長 Julie Talty一起共進晚宴…more